Syringes: Disposable Syringe

New ValiMed™ Medication Validation System And Related Information From Baxa Corporation Are Now Available At ... (PR Web via Yahoo! News) - 188 weeks ago

Englewood, CO (PRWeb) December 21, 2006 -- The new Valimed™ Medication Validation System and related information is now available at http:

New ValiMed™ Medication Validation System And Related Information From Baxa Corporation Are Now Available At ... (PR Web) - 188 weeks ago

The new Valimed™ Medication Validation System and related information are now available at PublicRelationsNewsroom.com The ValiMed System, distributed by Baxa Corporation, offers clinicians a simple and cost-effective tool to ensure medication safety by verifying that medications are correctly compounded. Its patent-pending technology identifies the strength to validate compounded doses of high ...

Tulip BioMed Comments on Revenue Projections and Conversion Rate of Reusable Users to Disposables (Market Wire via Yahoo! Finance) - 188 weeks ago

Tulip BioMed, Inc., a developer of medical devices and patented technologies for use in the living tissue market, including plastic, cosmetic, and orthopedic surgeries, comments on market acceptance and year-to-date sales of its disposable instruments.

Woman awarded $550,000 after partner dudded her (Northern Star) - 188 weeks ago

THE HEAD of a syringe-making company has been ordered to pay more than $500,000 to Byron Bay receptionist Louise White. Supreme Court judge Joseph Campbell in Sydney on Friday found Unilife Medical Solutions chief executive Alan Shortall owed Ms White $548,452 after she lent him $47,000.

TriMark Publications Announces Release of Its Nuclear Cardiology Markets Report (PR Web) - 188 weeks ago

TriMark Publications (http://www.trimarkpublications.com), a global leader in the biotechnology, healthcare and life sciences publishing, announces the release of its Nuclear Cardiology Markets report. (PRWeb Dec 18, 2006) Post Comment:Trackback URL: http://www.prweb.com/chachingpr.php/VGhpci1QaWdnLVNxdWEtVGhpci1NYWduLVplcm8=

TriMark Publications Announces Release of Its RNA Interference Markets Report (PR Web) - 188 weeks ago

TriMark Publications (http://www.trimarkpublications.com), a global leader in the biotechnology, healthcare and life sciences publishing, announces the release of its RNA Interference Markets report. (PRWeb Dec 18, 2006) Post Comment:Trackback URL: http://www.prweb.com/chachingpr.php/Q291cC1TcXVhLVNxdWEtVGhpci1NYWduLVplcm8=

TriMark Publications Announces Release of Its Stem Cell Markets Report (PR Web) - 188 weeks ago

TriMark Publications (http://www.trimarkpublications.com), a global leader in the biotechnology, healthcare and life sciences publishing, announces the release of its Stem Cell Markets report. (PRWeb Dec 18, 2006) Post Comment:Trackback URL: http://www.prweb.com/chachingpr.php/Q3Jhcy1QaWdnLVNxdWEtVGhpci1NYWduLVplcm8=

TriMark Publications Announces Release of Its RNA Interference Markets Report (PR Web via Yahoo! News) - 188 weeks ago

NEW YORK (PRWeb) December 18, 2006 -- TriMark Publications (http:

Tulip BioMed CEO Chosen as One of "Reader Favorites" in Inc. Magazine's Entrepreneur of the Year (SYS-CON Media) - 189 weeks ago

Founder and CEO Marc Pilkington of TulipBioMed(TM), Inc. (PINKSHEETS: TPBD), a developer of medical devices andpatented technologies for thelivingtissue markets, including plastic, cosmetic, and orthopedic surgeries,has been identified by Inc. Magazine as one of the top 13 'ReaderFavorites' in its Entrepreneur of the Year contest announced this week.

Tulip BioMed CEO Chosen as One of "Reader Favorites" in Inc. Magazine's Entrepreneur of the Year (Market Wire via Yahoo! Finance) - 189 weeks ago

Founder and CEO Marc Pilkington of Tulip BioMed(TM), Inc., a developer of medical devices and patented technologies for the living tissue markets, including plastic, cosmetic, and orthopedic surgeries, has been identified by Inc.